Results 141 to 150 of about 5,357,473 (408)

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study

npj Vaccines
Although HPV vaccines are highly efficacious, a notable proportion of quadrivalent vaccinees are HPV18 seronegative post-vaccination. We have investigated this findings’ validity by comparing vaccine-induced antibody responses using two different ...
Penelope Gray, Filipe Colaço Mariz, Carina Eklund, Tiina Eriksson, Helena Faust, Hanna Kann, Martin Müller, Jorma Paavonen, Ville N. Pimenoff, Peter Sehr, Heljä-Marja Surcel, Joakim Dillner, Tim Waterboer, Matti Lehtinen   +13 more
doaj   +1 more source

Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)

Xiehe Yixue Zazhi
Prophylactic human papilloma virus (HPV) vaccination is an effective strategy to prevent HPV infection and reduce the incidence of HPV-related diseases.Current clinical trials and real-world studies globally have demonstrated that prophylactic HPV ...
Society of Gynecologic Oncology, Chinese Medical Association, Branch of Colposcopy and Cervical Pathology, China Healthy Birth Science Association, Professional Committee on Cancer Prevention and Control, Chinese Preventive Medicine Association, Specialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research Association, National Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer Foundation, Committee on Cervical Cancer, China Anti-Cancer Association, Branch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health Care   +6 more
doaj   +1 more source

Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients [PDF]

, 2020
Introduction: A vaccine targeting high-risk human papillomavirus (HPV) strains can effectively prevent HPV-associated cervical cancer risk. However, many girls and women do not receive the vaccine, more often those impacted by health disparities ...
Galbraith, James W., Leader, Elizabeth, Walter, Lauren A.   +2 more
core  

Cervical cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index: A population‐based registry study

International Journal of Cancer, 2020
Cervical cancer is the leading cause of cancer death in African women. We sought to estimate population‐based survival and evaluate excess hazards for mortality in African women with cervical cancer, examining the effects of country‐level Human ...
M. Sengayi-Muchengeti, W. Y. Joko-Fru, A. Miranda-Filho, Marcel Egue, M. Akele-Akpo, G. N’da, A. Mathewos, N. Buziba, A. Korir, S. Manraj, C. Lorenzoni, C. Carrilho, Rolf Hansen, Anne Finesse, N. Somdyala, H. Wabinga, T. Chingonzoh, M. Borok, E. Chokunonga, Biying Liu, Elvira Singh, E. Kantelhardt, D. Parkin   +22 more
semanticscholar   +1 more source

Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium

Radiology and Oncology, 2019
The Hybrid Capture 2 (HC2) High-Risk HPV DNA assay serves as a triage test in the Slovenian national cervical cancer screening programme ZORA. To improve the limited analytical accuracy of HC2 test results near the cut-off value (1.0 relative light units/
Varl Jerneja, Ivanus Urska, Marinsek Ziva Pohar, Jerman Tine, Valencak Anja Ostrbenk, Poljak Mario, Prevodnik Veronika Kloboves   +6 more
doaj   +1 more source

Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study

BMJ Open, 2019
Objective The attendance rate for cervical cancer screening in Norway is currently suboptimal at 69%, and an in-depth understanding of postponement of cervical cancer screening from the perspective of non-attenders is lacking. This study aims to generate
Jo Waller, Kari Nyheim Solbraekke, Gunvor Aasbø, Ameli Tropé, Mari Nygård, Bo Terning Hansen   +5 more
doaj   +1 more source

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

Lancet Global Health, 2022
D. Singh, J. Vignat, V. Lorenzoni, Marzieh Eslahi, O. Ginsburg, Beatrice Lauby-Secretan, M. Arbyn, P. Basu, F. Bray, S. Vaccarella   +9 more
semanticscholar   +1 more source

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.

Journal of Clinical Oncology, 2019
PURPOSE KEYNOTE-158 ( ClinicalTrials.gov identifier: NCT02628067) is a phase II basket study investigating the antitumor activity and safety of pembrolizumab in multiple cancer types.
H. Chung, W. Ros, J. Delord, Ruth Perets, A. Italiano, R. Shapira-Frommer, L. Manzuk, S. Piha-Paul, Lei Xu, Susan Zeigenfuss, S. Pruitt, A. Leary   +11 more
semanticscholar   +1 more source

Knowledge, Attitude and Practice Towards Cervical Cancer Screening Among Women and Associated Factors in Hospitals of Wolaita Zone, Southern Ethiopia

Cancer Management and Research, 2020
Background Cervical cancer is a worldwide public health concern, and approximately 85% of deaths occurs in developing countries. Thus study is designed to assess knowledge, attitude, and practice towards cervical cancer screening in Wolaita Zone ...
Tadesse Tekle, E. Wolka, Banchialem Nega, W. P. Kumma, M. Koyira   +4 more
semanticscholar   +1 more source

A review of artificial intelligence in brachytherapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Artificial intelligence (AI) has the potential to revolutionize brachytherapy's clinical workflow. This review comprehensively examines the application of AI, focusing on machine learning and deep learning, in various aspects of brachytherapy.
Jingchu Chen, Richard L. J. Qiu, Tonghe Wang, Shadab Momin, Xiaofeng Yang   +4 more
wiley   +1 more source